BioCentury
ARTICLE | Company News

Tris Pharma, Vernalis deal

February 13, 2012 8:00 AM UTC

Tris granted Vernalis exclusive, North American rights to commercialize six reformulated cough and cold products using Tris' extended release formulation technology. Tris, which will be responsible fo...